Clinical Trial Update: Five-Year Actively Controlled Clinical Trial in New Onset Juvenile Systemic Lupus Erythematosus Nephritis [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial in new onset juvenile systemic lupus erythematosus nephritis was withdrawn from the registry.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Systemic Lupus Erythematosus Nephritis

Snippet

Sponsor: Istituto Giannina Gaslini | Conditions: Systemic Lupus Erythematosus Nephritis | Phase 3 | Status: WITHDRAWN